Home
>
National Drug Code (NDC)
>
Mirtazapine
Mirtazapine - 0591-2230-15 - (Mirtazapine)
Drug Information of Mirtazapine
| Product NDC: | 0591-2230 |
| Proprietary Name: | Mirtazapine |
| Non Proprietary Name: | Mirtazapine |
| Active Ingredient(s): | 15 mg/1 & nbsp; Mirtazapine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Mirtazapine
| Product NDC: | 0591-2230 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076307 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20081201 |
Package Information of Mirtazapine
| Package NDC: | 0591-2230-15 |
| Package Description: | 5 BLISTER PACK in 1 CARTON (0591-2230-15) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
NDC Information of Mirtazapine
| NDC Code | 0591-2230-15 |
| Proprietary Name | Mirtazapine |
| Package Description | 5 BLISTER PACK in 1 CARTON (0591-2230-15) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
| Product NDC | 0591-2230 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Mirtazapine |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20081201 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | MIRTAZAPINE |
| Strength Number | 15 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
